Chargement en cours...
hiPSC‐derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine
Mesenchymal stem cells (MSCs) are being assessed for ameliorating the severity of graft‐versus‐host disease, autoimmune conditions, musculoskeletal injuries and cardiovascular diseases. While most of these clinical therapeutic applications require substantial cell quantities, the number of MSCs that...
Enregistré dans:
| Publié dans: | J Cell Mol Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956943/ https://ncbi.nlm.nih.gov/pubmed/27097531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12839 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|